Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Bolsa de valores de Sao Paulo  >  Fleury SA    FLRY3   BRFLRYACNOR5

FLEURY SA (FLRY3)
Mes dernières consult.
Most popular
End-of-day quote. End-of-day quote  - 09/20
28.25 BRL   --.--%
06/15 NOTICE TO THE M : Public Civil Action
06/02 FLEURY : Call Notice to General Extraordinary Shareholders’ Me..
04/10 NOTICE TO THE M : change in management
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Notice to the Market: Public Civil Action

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/15/2017 | 12:39am CEST

FLEURY S.A.

Public Company

CNPJ nº 60.840.055/0001-31 NIRE nº 35.300.197.534

Notice to the Market Public Civil Action São Paulo, June 14th, 2017 - In order to update its Shareholders and the market in general, in line with the Relevant Fact published on June 21st, 2013 and Notice to the Market published on March 13th, 2014, Grupo Fleury S.A ("Fleury" or "the Company") informs that the Regional Labor Court at the 1st Region (in Rio de Janeiro) has partially modified the decision ruled by the City Court regarding the Class Action ("Public Civil Action"), in which is challenged the legality of hiring specialized medical companies by Fleury. The Company will file an appeal and an injunction to the Superior Court, seeking to revert and suspend the decision.

The likelihood of success of the final outcome of the case was not altered as per the assessment of the external legal advisors, due to existing precedents at the Superior Labor Court.

Viviane Behar de Castro

Investor Relations Officer

Fleury SA published this content on 14 June 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 14 June 2017 22:39:18 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FLEURY SA
06/15 NOTICE TO THE MARKET : Public Civil Action
06/02 FLEURY : Call Notice to General Extraordinary Shareholders’ Meeting
04/10 NOTICE TO THE MARKET : change in management
03/10 FLEURY : Payment of dividends
2016 FLEURY : Payment of Dividends and Interest on Shareholders’ Equity
2016 FLEURY : Grupo Fleury announces its 3Q16 results schedule and quiet period
2016 NOTICE TO THE MARKET : reduction of ownership participation
2016 COMUNICADO AO MEFRCADO : redução de participação da Invesco
2016 FLEURY : Grupo Fleury launches the new version of the Investor Relations website
2016 FLEURY : Grupo Fleury integrates IBrX100 portfolio
More news
Financials ( BRL)
Sales 2017 2 393 M
EBIT 2017 468 M
Net income 2017 308 M
Debt 2017 341 M
Yield 2017 1,49%
P/E ratio 2017 27,32
P/E ratio 2018 21,82
EV / Sales 2017 3,86x
EV / Sales 2018 3,33x
Capitalization 8 893 M
Chart FLEURY SA
Duration : Period :
Fleury SA Technical Analysis Chart | FLRY3 | BRFLRYACNOR5 | 4-Traders
Technical analysis trends FLEURY SA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 29,2  BRL
Spread / Average Target 3,4%
EPS Revisions
Managers
NameTitle
Carlos Alberto Iwata Marinelli Chief Executive Officer
Marcos Bosi Ferraz Chairman
Fernando Augusto Rodrigues Leão Filho Chief Financial Officer
Jeane Tsutsui Executive Director-Medical & Technical
Samuel Monteiro dos Santos Director
Sector and Competitors
1st jan.Capitalization (M$)
FLEURY SA70.61%2 841
SONIC HEALTHCARE LIMITED-1.22%7 148
DR. LAL PATHLABS LTD-24.02%1 038
BML INC-13.89%947
NEOGENOMICS, INC.24.50%852
THYROCARE TECHNOLOGIES LTD-1.59%567